BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10379511)

  • 1. Spinal cord dose is higher than expected in head and neck radiation.
    Allison R; Vaughan J; Thurber A; Rajecki M; Vongtama V; Barry T
    Med Dosim; 1999; 24(2):135-9. PubMed ID: 10379511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation injury to the spinal cord in head and neck cancers: does field arrangement have a role.
    Anusheel M; Prabhakar R; Mohanti BK
    J Cancer Res Ther; 2006; 2(2):65-7. PubMed ID: 17998677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The midline dose distribution for a three-field radiotherapy technique.
    Meeks SL; Williams RO; Bova FJ; Mendenhall WM; Buatti JM
    Med Dosim; 1999; 24(2):91-8. PubMed ID: 10379506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer.
    Mul VE; de Jong JM; Murrer LH; van den Ende PL; Houben RM; Lacko M; Lambin P; Baumert BG
    Strahlenther Onkol; 2012 Jan; 188(1):71-6. PubMed ID: 22194023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of myelitis after irradiation of the cervical spinal cord.
    Marcus RB; Million RR
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):3-8. PubMed ID: 2380091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En-bloc irradiation of tumours of the head and neck and their lymphatics. II. Early results and side effects.
    Andersson T; Biörklund A; Landberg T; Mercke C; Svahn-Tapper G
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(3):189-98. PubMed ID: 99984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater.
    Jeremic B; Djuric L; Mijatovic L
    Cancer; 1991 Nov; 68(10):2138-41. PubMed ID: 1913452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technical realization of a systematized radiation therapy, founded on the TNM system, of tumors in the regions of the head and neck (author's transl)].
    Ammon J; Löffler R; Stockberg H; Zeumer H
    Strahlentherapie; 1978 Aug; 154(8):511-9. PubMed ID: 98865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
    Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
    Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation tolerance of the cervical spinal cord.
    Kim YH; Fayos JV
    Radiology; 1981 May; 139(2):473-8. PubMed ID: 7220892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a simple asymmetric jaw technique in the treatment of head and neck cancer.
    Roberge D; Gosselin M; Sultanem K; Corns R; Shenouda G
    Radiother Oncol; 2003 Aug; 68(2):149-52. PubMed ID: 12972309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning.
    Martel MK; Eisbruch A; Lawrence TS; Fraass BA; Ten Haken RK; Lichter AS
    Radiother Oncol; 1998 May; 47(2):185-9. PubMed ID: 9683367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiation-induced myelopathy].
    Kasperek S; Motta E
    Neurol Neurochir Pol; 1985; 19(2):144-8. PubMed ID: 3900781
    [No Abstract]   [Full Text] [Related]  

  • 14. Peridose, a software program to calculate the dose outside the primary beam in radiation therapy.
    van der Giessen PH
    Radiother Oncol; 2001 Feb; 58(2):209-13. PubMed ID: 11166873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beam number on organ-at-risk sparing in dynamic multileaf collimator delivery of intensity modulated radiation therapy.
    Popple RA; Fiveash JB; Brezovich IA
    Med Phys; 2007 Oct; 34(10):3752-9. PubMed ID: 17985620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation myelopathy of the cervical spinal cord: time, dose and volume factors.
    Abbatucci JS; Delozier T; Quint R; Roussel A; Brune D
    Int J Radiat Oncol Biol Phys; 1978; 4(3-4):239-48. PubMed ID: 640895
    [No Abstract]   [Full Text] [Related]  

  • 17. Mid-sagittal plane dosimetry in patients with extensive head and neck malignancy.
    Paradelo JC; Ucmakli A; Schiller B; Sternick E; Mower H
    Int J Radiat Oncol Biol Phys; 1981 Jan; 7(1):115-20. PubMed ID: 7263333
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation therapy in the management of lymph node metastases from head and neck cancers.
    Wizenberg MJ; Bloedorn FG; Weiner S; Gracia JR
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):76-82. PubMed ID: 4621578
    [No Abstract]   [Full Text] [Related]  

  • 19. Lhermitte's sign following head and neck radiotherapy.
    Lewanski CR; Sinclair JA; Stewart JS
    Clin Oncol (R Coll Radiol); 2000; 12(2):98-103. PubMed ID: 10853747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation myelopathy of cervical spinal cord simulating intramedullary neoplasm.
    Fogelholm R; Haltia M; Andersson LC
    J Neurol Neurosurg Psychiatry; 1974 Oct; 37(10):1177-80. PubMed ID: 4443812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.